Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AptarGroup is seeking FDA Emergency Use Authorization for a solution that allows easy disinfecting of N95 filtering facepiece respirators.
read more
AptarGroup and Sonmol have announced a collaboration for developing a digital therapies and services platform targeting respiratory and other diseases.
read more
AptarGroup announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited’s Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction.
read more
Aptuit, LLC has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research Organization dedicated to early phase drug discovery solutions.
read more
Aptuit has acquired Kuecept Ltd to meet strong customer demand for specialist drug pre-formulation, formulation prototyping and formulation development services.
read more
Wednesday, January 04, 2017
Aptuit and Chiesi Farmaceutici have entered an agreement under which Aptuit will conduct an integrated Discovery Project aimed at providing innovative drugs to treat Idiopathic Pulmonary Fibrosis.
read more
Aptuit and Dimension Therapeutics have announced a strategic partnership agreement under which Aptuit will support GLP IND-enabling studies for select rare disease programs at Dimension. Three key integrated development projects have initiated under ...
read more
Tuesday, November 13, 2012
Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy...
read more
Wednesday, February 24, 2016
Aptuit and Icagen have announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.
read more
Monday, December 07, 2015
Aptuit announced it has commenced a growth program for 2016 to meet significant increase in demand from customers in discovery, Chemistry, Manufacturing and Controls (CMC) and non-clinical development.
read more
Aptuit announced a strategic provider relationship between Aptuit and Regulus Therapeutics.
read more
Jonathan Goldman, CEO of Aptuit LLC, announced that Henning Steinhagen, PhD, has been named as President, Research and Development Operations. Henning will continue in his existing role of Site-Head at Aptuit, Verona, Italy whilst assuming oversight...
read more
Tuesday, January 24, 2017
Aptuit has announced the start of a collaboration with the Molecular Surgical Laboratory of Massachusetts General Hospital (MGH), directed by Dr. Laurence Rahme, aimed at the identification and validation of novel targets in Gram-negative bacteria. ...
read more
Thursday, October 13, 2016
Aptuit has relocated its recently acquired subsidiary Kuecept to its Oxford UK site, and added further formulation and safety assessment capacity to meet sustained customer demand for IND de-risking and enabling packages.
read more
Wednesday, November 30, 2016
Aptuit announced that it has successfully completed the expansion of their lead-like screening library. An additional 150,000 novel compounds have increased the Screening Collection to over 400,000.
read more